Skip to content

Evaluation the effect of supportive-expressive dynamic psychotherapy in Bipolar Spectrum patients

Evaluation the effectiveness of supportive-expressive dynamic psychotherapy in improving the treatment outcome of Bipolar Spectrum Disorders in Male Hospitalized Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180716040485N1
Enrollment
36
Registered
2019-09-15
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Mood Disorders. Bipolar disorder

Interventions

Intervention 1: Control group: Adult male patients with bipolar disorder treated under medical treatment. Intervention 2: Intervention group: The men patients with bipolar disorder received drug treat

Sponsors

Islamic Azad University (IAU )
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Having bipolar mood disorder based on psychiatrist's diagnosis Hospitalized Normal IQ. Male gender. Lack of co-morbid physical and organic serious problems (Including sensory impairments such as deafness and blindness, severe physical disabilities) No cognitive impairment that interferes with understanding and participating in treatment The absence of other serious psychiatric disorders (e.g.psychotic symptoms , anxiety disorders,...)

Exclusion criteria

Exclusion criteria: The patient's unwillingness to continue the participation in study Absence for more than one session and the absence in the session considered as compensated session Hospital discharging

Design outcomes

Primary

MeasureTime frame
Bipolar disorder level. Timepoint: BDRS scores at the beginning of the study (maintenance phase), immediately after the completion of psychological interventions 1 month, 3 months and 6 months after the start of the study in the supportive-psychotic recipient group, along with drug therapies. Method of measurement: The BDRS and its subscales in the sample of Iranian patients have a construct validity, ownership, distinction, and diagnosis that can be used in surveying and clinical trials.;Relapse Rate. Timepoint: 1 Month after intervention, 3 Month After Interventions , 6 Month after Intervention. Method of measurement: Bipolar Disorder Rating Scale (BDRS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Bornamanesh

Esfahan University of Medical Sciences

Bornamanesh@miau.ac.ir+98 31 3773 6684

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026